CRIS Curis, Inc. - Common Stock
$1,88
Preço · Ago 18, 2026
Fundamentais a partir de Ago 14, 2026
Intervalo 52 Semanas
$0–$9
19% of range
Classificação do Analista
BUY
10 analysts
Preço-Alvo
$43
+2170% upside
P/E (TTM)
-0.2
ROE
177.9%
Margem de Lucro Líquido
-80.3%
CRIS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.88
Capitalização de Mercado
$1M
P/E (TTM)
-0.2
EPS (TTM)
$-0.58
Receita (TTM)
$9M
Rendimento div.
—
ROE
177.9%
Dívida/Capital
0.0
Intervalo 52 Semanas
$0 – $9
CRIS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$9M
2016-12-31
→
2025-12-31
EPS
$-0.58
2019-12-31
→
2025-12-31
Fluxo de caixa livre
—
2016-12-31
→
2023-12-31
Margens
-80.3%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
CRIS
Mediana de Pares
P/E (TTM)
-0.2
—
P/S (TTM)
0.1
2.9
P/B
0.2
1.1
EV / EBITDA
0.7
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
CRIS
Mediana de Pares
Operating Margin (Margem Operacional)
-60.5%
—
Net Profit Margin (Margem de Lucro Líquido)
-80.3%
-4409.1%
ROA
-24.8%
-111.4%
ROE
177.9%
-169.4%
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
CRIS
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
0.0
0.0
Current Ratio (Índice de liquidez corrente)
0.5
1.9
Quick Ratio (Índice de Liquidez Seca)
0.4
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
CRIS
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-13.4%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-2.4%
—
Revenue CAGR 5Y (CAGR Receita 5A)
-2.7%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
CRIS
Mediana de Pares
CRIS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
10 analistas
- Compra forte 2 20,0%
- Compra 7 70,0%
- Manter 1 10,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
3 analistas · 2026-08-16
Mediana
$43.00
← Abaixo de todos os alvos
$1.88
Mín
$20.00
Máx
$65.00
Alvo mediano
$43.00
+2187,2%
Alvo médio
$42.67
+2169,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-1.8%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-25.00 | $-8.16 | -16.8% |
| 31 de Dezembro de 2025 | $-10.00 | $-9.18 | -0.82% |
| 30 de Setembro de 2025 | $-9.80 | $-11.79 | 2.0% |
| 30 de Junho de 2025 | $-13.60 | $-18.16 | 4.6% |
| 31 de Março de 2025 | $-1.25 | $-1.21 | -0.04% |
| 31 de Dezembro de 2024 | $-1.25 | $-1.39 | 0.14% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| RNAZ | — | -0.1 | — | — | — | — |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| BIAF | — | — | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $18M | · | $14M | |
| SG&A Expense | $14M | $17M | $19M | $20M | $17M | $12M | $12M | $15M | $14M | $16M | $13M | $12M | |
| Operating Expenses | $42M | $55M | $58M | $63M | $53M | $36M | $34M | $40M | $60M | $66M | $64M | $26M | |
| Operating Income | $-6M | $-45M | $-48M | $-53M | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M | |
| Interest Expense | · | · | · | · | $0 | $0 | $791.0K | $4M | $4M | $3M | $3M | $4M | |
| Interest Income | $316.0K | $2M | $3M | $1M | $211.0K | $63.0K | $614.0K | $684.0K | $513.0K | $406.0K | $277.0K | $165.0K | |
| Other Non-op | $-2M | $1M | $919.0K | $-4M | $890.0K | $22.0K | $-58.0K | $0 | $-4M | $-2M | $-2M | $-3M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| EPS (Basic) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| EPS (Diluted) | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 | $-0.61 | $-0.97 | · | · | · | · | · | |
| Shares (Basic) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| Shares (Diluted) | 13,164,032 | 6,306,284 | 5,293,294 | 4,669,626 | 91,569,154 | 48,670,381 | 33,180,516 | · | · | · | · | · | |
| EBITDA | $-6M | $-45M | $-48M | · | $-42M | $-25M | $-24M | $-29M | $-50M | $-58M | $-56M | $-16M |
Balanço Patrimonial 27
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $20M | $27M | $20M | $40M | $130M | $15M | $24M | $38M | $26M | $33M | $8M | |
| Short-term Investments | · | $0 | $30M | $66M | $76M | $39M | $5M | $634.0K | $22M | $18M | $49M | $42M | |
| Receivables | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Prepaid Expense | $2M | $3M | $2M | $4M | $3M | $1M | $1M | $827.0K | $989.0K | $1M | $1M | $489.8K | |
| Current Assets | $7M | $26M | $61M | $92M | $122M | $173M | $25M | $28M | $64M | $48M | $86M | $52M | |
| PP&E (Net) | $62.0K | $231.0K | $434.0K | $689.0K | $505.0K | $663.0K | $154.0K | $267.0K | $400.0K | $400.0K | $300.0K | $407.7K | |
| PP&E (Gross) | $913.0K | $1M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $851.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $3M | $2M | $0 | $3.0K | $3.0K | $2.0K | $3.0K | $3.0K | $51.0K | $67.5K | |
| Total Assets | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Accounts Payable | $6M | $3M | $3M | $3M | $6M | $4M | $4M | $3M | $5M | $6M | $4M | $2M | |
| Accrued Liabilities | $7M | $7M | $9M | $6M | $6M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Current Liabilities | $14M | $19M | $22M | $10M | $13M | $10M | $7M | $13M | $14M | $14M | $11M | $10M | |
| Capital Leases | $428.0K | $2M | $1M | $3M | $4M | $5M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $334.0K | $0 | $11.0K | $34.0K | $18.0K | $139.0K | $174.0K | |
| Total Liabilities | $15M | $47M | $58M | $62M | $72M | $74M | $69M | $42M | $50M | $28M | $30M | $33M | |
| Long-term Debt | · | · | · | · | · | $891.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Total Debt | $0 | $8M | · | · | $0 | $557.0K | $0 | $35M | $42M | $20M | $24M | $28M | |
| Common Stock | $6.0K | $85.0K | $59.0K | $48.0K | $916.0K | $915.0K | $332.0K | $332.0K | $331.0K | $1M | $1M | $872.5K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $810M | |
| Retained Earnings | $-1.25B | $-1.24B | $-1.20B | $-1.15B | $-1.09B | $-1.05B | $-1.02B | $-985M | $-952M | $-899M | $-839M | $-780M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | |
| AOCI | · | $0 | $229.0K | $-186.0K | $-109.0K | $-3.0K | $0 | $0 | $-2.0K | $-4.0K | $28.0K | $-11.0K | |
| Stockholders' Equity | $5M | $-6M | $20M | $47M | $91M | $131M | $-34M | $-4M | $24M | $29M | $65M | $30M | |
| Liabilities + Equity | $20M | $41M | $77M | $109M | $162M | $204M | $35M | $37M | $74M | $58M | $95M | $63M | |
| Shares Outstanding | 646,537 | 8,487,818 | 5,894,085 | 4,830,464 | 91,645,369 | 91,502,461 | 33,241,793 | 33,159,253 | 32,831,380 | 141,124,025 | 128,990,378 | 86,030,811 |
Fluxo de Caixa 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $169.0K | $203.0K | $255.0K | $233.0K | $158.0K | $144.0K | $125.0K | $177.0K | $235.0K | $193.0K | $200.0K | $200.0K | |
| Stock-based Comp | $4M | $6M | $6M | $7M | $5M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | |
| Operating Cash Flow | $-27M | $-40M | $-38M | $-54M | $-38M | $-26M | $-26M | $-30M | $-48M | $-36M | $-30M | $-17M | |
| CapEx | · | · | $0 | $416.0K | $0 | $677.0K | $41.0K | $85.0K | $188.0K | $329.0K | $48.0K | $92.0K | |
| Investing Cash Flow | $2M | $29M | $38M | $33M | $-48M | $-49M | $-4M | $21M | $-4M | $30M | $-6M | $16M | |
| Stock Issued | $15M | $12M | $14M | $6M | $0 | $159M | $0 | $0 | $42M | $0 | $65M | $0 | |
| Net Stock Activity | $15M | $12M | $14M | · | $0 | $159M | · | $0 | $42M | $0 | $65M | $282.8K | |
| Financing Cash Flow | $10M | $3M | $8M | $867.0K | $-4M | $189M | $23M | $-6M | $64M | $-1M | $62M | $-1M | |
| Net Change in Cash | $-15M | $-7M | $7M | $-20M | $-90M | $114M | $-7M | $-15M | $12M | $-7M | $25M | $-2M | |
| Free Cash Flow | · | · | $-38M | · | $-38M | $-26M | $-26M | $-30M | $-49M | $-36M | $-30M | $-17M |
Lucratividade 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| Net Margin | -80.3% | -397.8% | -473.0% | · | -426.7% | -276.0% | -320.9% | -312.6% | -538.7% | -802.6% | -748.6% | -190.3% | |
| EBITDA Margin | -60.5% | -408.3% | -482.2% | · | -395.0% | -229.8% | -243.5% | -281.3% | -502.7% | -771.1% | -716.9% | -161.1% | |
| ROA | -24.8% | -73.2% | -50.9% | · | -24.8% | -25.0% | -88.6% | -58.7% | -81.1% | -79.1% | -74.9% | -26.2% | |
| ROE | 177.9% | 589.0% | -192.5% | · | -46.9% | -58.6% | 107.1% | 1755.5% | -199.5% | -128.8% | -125.1% | -50.0% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.4 | 4.5 | · | 9.1 | 17.1 | 3.8 | 2.1 | 4.6 | 3.6 | 7.9 | 5.2 | |
| Quick Ratio | 0.4 | 1.2 | 4.4 | · | 8.9 | 17.0 | 3.6 | 2.0 | 4.5 | 3.5 | 7.8 | 5.1 | |
| Debt / Equity | 0.0 | -1.3 | · | · | 0.0 | 0.0 | 0.0 | -7.9 | 1.7 | 0.7 | 0.4 | 1.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | -6.4 | 1.5 | 0.5 | 0.3 | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | -30.8 | -7.5 | -12.5 | -20.9 | -17.0 | -4.2 |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | 5.6 | 3.6 | 3.5 | · | 3.4 | 3.4 | 3.3 | 3.5 | 3.6 | 3.3 | 3.9 | 5.7 |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.4% | 8.8% | -1.4% | -4.6% | -1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | 0.80% | -2.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.7% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $11M | $10M | $10M | $11M | $11M | $10M | $10M | $10M | $8M | $8M | $10M | |
| Net Income TTM | $-8M | $-43M | $-47M | $-57M | $-45M | $-30M | $-32M | $-33M | $-53M | $-60M | $-59M | $-19M | |
| Market Cap | $13M | $26M | $75M | · | $8.72B | $14.99B | $1.13B | $458M | $11.49B | $43.47B | $37.54B | $12.90B | |
| Enterprise Value | $8M | $14M | · | · | $8.61B | $14.82B | $1.11B | $469M | $11.47B | $43.44B | $37.48B | $12.88B | |
| P/E | -1.7 | -0.4 | -1.4 | -0.9 | 190.4 | -268.5 | -35.1 | · | · | · | · | · | |
| P/S | 1.4 | 2.4 | 7.5 | · | 819.3 | 1383.3 | 113.0 | 43.9 | 1160.9 | 5774.7 | 4764.7 | 1311.0 | |
| P/B | 2.3 | -4.3 | 3.8 | · | 96.2 | 114.7 | -33.3 | -101.8 | 478.9 | 1485.2 | 581.9 | 433.3 | |
| P / Tangible Book | · | · | 7.0 | 28.3 | 106.8 | 123.2 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -0.7 | -2.0 | · | -231.9 | -582.3 | -43.1 | -15.2 | -237.6 | -1213.8 | -1255.8 | -767.5 | |
| P / FCF | · | · | -2.0 | · | -231.9 | -567.4 | -43.1 | -15.2 | -236.7 | -1202.7 | -1253.8 | -763.4 | |
| EV / EBITDA | -1.4 | -0.3 | · | · | -204.7 | -595.2 | -45.6 | -16.0 | -230.6 | -748.5 | -663.6 | -812.2 | |
| EV / FCF | · | · | · | · | -228.8 | -561.0 | -42.3 | -15.5 | -236.3 | -1202.0 | -1251.8 | -762.1 | |
| EV / Revenue | 0.8 | 1.2 | · | · | 808.4 | 1367.8 | 110.9 | 45.0 | 1159.1 | 5771.4 | 4757.3 | 1308.9 | |
| Earnings Yield | -58.6% | -224.8% | -70.3% | -110.4% | 0.53% | -0.37% | -2.9% | · | · | · | · | · |
Demonstração de Resultados 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $3M | $5M | $3M | $4M | $4M | $4M | $3M | $4M | $5M | $5M | $5M | $5M | $4M | $5M | $4M | $5M | |
| Operating Expenses | $10M | $12M | $9M | $10M | $11M | $13M | $12M | $13M | $15M | $15M | $15M | $15M | $14M | $14M | $13M | $15M | |
| Operating Income | $-10M | $-12M | $20M | $-7M | $-8M | $-10M | $-9M | $-11M | $-13M | $-12M | $-12M | $-12M | $-12M | $-12M | $-10M | $-13M | |
| Interest Income | $62.0K | $77.0K | $51.0K | $80.0K | $92.0K | $93.0K | $227.0K | $325.0K | $701.0K | $515.0K | $665.0K | $806.0K | $815.0K | $652.0K | $542.0K | $335.0K | |
| Other Non-op | $1M | $-13M | $-263.0K | $-805.0K | $-342.0K | $-459.0K | $-624.0K | $475.0K | $709.0K | $593.0K | $487.0K | $187.0K | $177.0K | $68.0K | $-1M | $-688.0K | |
| Net Income | $-9M | $-24M | $19M | $-8M | $-9M | $-11M | $-10M | $-10M | $-12M | $-12M | $-12M | $-12M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| EPS (Diluted) | $-4.02 | $-1.25 | $1.84 | $-0.49 | $-13.61 | $-1.25 | $-1.10 | $-1.70 | $-2.03 | $-2.05 | $-1.97 | $-2.13 | $-2.47 | $-2.39 | $-8.96 | $-2.83 | |
| Shares (Basic) | 2,135,906 | 19,363,478 | -23,637,672 | 15,680,178 | 631,475 | 8,493,886 | -11,236,641 | 5,940,924 | 5,818,416 | 5,783,585 | -10,092,639 | 5,720,789 | 4,834,381 | 4,830,763 | -183,316,252 | 4,689,559 | |
| Shares (Diluted) | 2,135,906 | 19,363,478 | -23,637,672 | 15,680,178 | 631,475 | 8,493,886 | -11,236,641 | 5,940,924 | 5,818,416 | 5,783,585 | -10,092,639 | 5,720,789 | 4,834,381 | 4,830,763 | -183,316,252 | 4,689,559 | |
| EBITDA | $-10M | $-12M | · | $-7M | $-8M | $-10M | · | $-11M | $-13M | $-12M | · | $-12M | $-12M | $-12M | · | $-13M |
Balanço Patrimonial 23
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $15M | $5M | $9M | $10M | $20M | $20M | $21M | $10M | $30M | $27M | $24M | $20M | $32M | $20M | $30M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $18M | $11M | $30M | $44M | $44M | $40M | $66M | $69M | |
| Receivables | · | · | $0 | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Prepaid Expense | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $4M | $4M | $4M | |
| Current Assets | $7M | $17M | $7M | $14M | $14M | $25M | $26M | $27M | $35M | $46M | $61M | $73M | $68M | $78M | $92M | $106M | |
| PP&E (Net) | $46.0K | $54.0K | $62.0K | $98.0K | $130.0K | $172.0K | $231.0K | $246.0K | $308.0K | $370.0K | $434.0K | $497.0K | $561.0K | $625.0K | $689.0K | $780.0K | |
| PP&E (Gross) | · | · | $913.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $851.0K | · | · | · | $1M | · | · | · | $2M | · | · | · | $2M | · | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Total Assets | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Accounts Payable | $5M | $7M | $6M | $4M | $4M | $5M | $3M | $4M | $2M | $4M | $3M | $5M | $3M | $3M | $3M | $6M | |
| Accrued Liabilities | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $8M | $7M | $6M | $9M | $7M | $6M | $4M | $6M | $7M | |
| Current Liabilities | $14M | $15M | $14M | $20M | $19M | $20M | $19M | $22M | $19M | $11M | $22M | $14M | $10M | $8M | $10M | $14M | |
| Capital Leases | $0 | $108.0K | $428.0K | $740.0K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | |
| Total Liabilities | $14M | $17M | $15M | $42M | $43M | $46M | $47M | $51M | $51M | $53M | $58M | $60M | $58M | $58M | $62M | $67M | |
| Total Debt | · | · | · | $7M | $7M | $7M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $400.0K | $129.0K | $127.0K | $107.0K | $105.0K | $85.0K | $60.0K | $59.0K | $59.0K | $59.0K | $59.0K | $993.0K | $966.0K | $48.0K | $964.0K | |
| Retained Earnings | $-1.28B | $-1.27B | $-1.25B | $-1.27B | $-1.26B | $-1.25B | $-1.24B | $-1.23B | $-1.22B | $-1.21B | $-1.20B | $-1.18B | $-1.17B | $-1.16B | $-1.15B | $-1.14B | |
| AOCI | · | · | · | · | · | · | · | $0 | $42.0K | $338.0K | $229.0K | $103.0K | $2.0K | $9.0K | $-186.0K | $-479.0K | |
| Stockholders' Equity | $5M | $13M | $5M | $-15M | $-14M | $-7M | $-6M | $-9M | $-694.0K | $9M | $20M | $30M | $26M | $37M | $47M | $56M | |
| Liabilities + Equity | $19M | $30M | $20M | $28M | $29M | $39M | $41M | $42M | $50M | $62M | $77M | $90M | $84M | $95M | $109M | $123M | |
| Shares Outstanding | 1,949,041 | 39,978,693 | 12,928,853 | 12,733,853 | 10,708,393 | 10,462,250 | 8,487,818 | 6,020,259 | 5,904,278 | 5,894,085 | 5,894,085 | 5,885,313 | 99,344,798 | 96,617,898 | 4,830,464 | 96,398,360 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $36.0K | $32.0K | $42.0K | $59.0K | $16.0K | $61.0K | $62.0K | $64.0K | $64.0K | $63.0K | $64.0K | $64.0K | $92.0K | $61.0K | |
| Stock-based Comp | $569.0K | $575.0K | $795.0K | $924.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Operating Cash Flow | $-10M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | $-6M | $-11M | $-13M | $-10M | $-8M | $-8M | $-12M | $-12M | $-13M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $52.0K | |
| Investing Cash Flow | $0 | $0 | $2M | $0 | $0 | $0 | $-428.0K | $18M | $-7M | $19M | $15M | $180.0K | $-3M | $26M | $3M | $4M | |
| Stock Issued | $-282.0K | $19M | $-119.0K | $6M | $-578.0K | $10M | $11M | $696.0K | $291.0K | $0 | $118.0K | $14M | $178.0K | $7.0K | $179.0K | · | |
| Net Stock Activity | · | $19M | · | · | · | $10M | · | · | · | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-282.0K | $19M | $-119.0K | $4M | $-2M | $8M | $9M | $-2M | $-1M | $-2M | $-2M | $13M | $-852.0K | $-2M | $-1M | $5M | |
| Net Change in Cash | $-10M | $10M | $-4M | $-1M | $-10M | $285.0K | $-857.0K | $11M | $-20M | $3M | $2M | $5M | $-12M | $12M | $-10M | $-4M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-12M | · | · |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| Net Margin | · | · | · | -243.4% | -312.6% | -446.0% | · | -344.3% | -463.6% | -569.3% | · | -430.0% | -544.4% | -503.2% | · | -470.6% | |
| EBITDA Margin | · | · | · | -218.0% | -300.1% | -426.8% | · | -360.5% | -491.4% | -597.8% | · | -436.6% | -552.5% | -506.2% | · | -446.2% | |
| ROA | -35.6% | -70.1% | · | -22.1% | -21.6% | -20.9% | · | -15.2% | -17.5% | -15.2% | · | -11.5% | -11.2% | -9.8% | · | -9.0% | |
| ROE | 184.7% | -793.4% | · | 66.0% | 117.1% | -743.7% | · | -96.8% | -92.5% | -51.6% | · | -28.5% | -27.1% | -20.5% | · | -16.8% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | 1.1 | · | 0.7 | 0.7 | 1.2 | · | 1.2 | 1.8 | 4.1 | · | 5.4 | 7.0 | 9.7 | · | 7.7 | |
| Quick Ratio | 0.4 | 1.0 | · | 0.6 | 0.7 | 1.1 | · | 1.1 | 1.6 | 3.8 | · | 5.2 | 6.8 | 9.2 | · | 7.4 | |
| Debt / Equity | · | · | · | -0.5 | -0.5 | -1.1 | · | · | · | · | · | · | · | · | · | · |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 0.9 | 1.1 | · | 1.0 |
Avaliação (TTM) 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $8M | · | $11M | $11M | $10M | · | $10M | $10M | $9M | · | $10M | $10M | $10M | · | $10M | |
| Net Income TTM | $-49M | $-51M | · | $-37M | $-41M | $-44M | · | $-46M | $-48M | $-48M | · | $-49M | $-53M | $-57M | · | $-56M | |
| Market Cap | $1M | $22M | · | $21M | $25M | $22M | · | $32M | $41M | $64M | · | $39M | $1.65B | $1.16B | · | $1.35B | |
| Enterprise Value | · | · | · | $19M | $22M | $9M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.1 | · | -0.4 | -0.4 | -0.3 | · | -0.7 | -0.8 | -1.2 | · | -0.7 | -2.1 | -2.2 | · | -4.2 | |
| P/S | 0.2 | 2.6 | · | 1.9 | 2.3 | 2.2 | · | 3.1 | 4.2 | 6.8 | · | 3.8 | 169.8 | 121.1 | · | 130.8 | |
| P/B | 0.2 | 1.7 | · | -1.4 | -1.8 | -3.3 | · | -3.7 | -58.7 | 6.8 | · | 1.3 | 62.9 | 31.7 | · | 24.2 | |
| P / Tangible Book | · | 5.9 | · | · | · | · | · | · | · | 133.5 | · | 1.9 | 95.6 | 42.0 | · | 28.9 | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.0 | · | · | · | -4.8 | · | · | · | -95.0 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -95.0 | · | · | |
| EV / EBITDA | · | · | · | -2.7 | -2.7 | -0.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 1.7 | 2.1 | 0.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3725.0% | -667.3% | · | -248.2% | -244.0% | -334.8% | · | -146.8% | -125.8% | -83.2% | · | -149.0% | -47.3% | -46.4% | · | -23.6% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $9M | $11M | $10M | $10M | $11M |
| Margem Operacional % | -60.5% | -408.3% | -482.2% | — | -395.0% |
| Lucro líquido | $-8M | $-43M | $-47M | $-57M | $-45M |
| EPS Diluído | $-0.58 | $-6.88 | $-8.96 | $-12.14 | $0.50 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.0 | -1.3 | — | — | 0.0 |
| Índice de liquidez corrente | 0.5 | 1.4 | 4.5 | — | 9.1 |
| Índice de Liquidez Seca | 0.4 | 1.2 | 4.4 | — | 8.9 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | — | — | $-38M | — | $-38M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 39 declarantes · $7.0M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 9 (+1 vs trimestre anterior) | 12 (+4 vs trimestre anterior) | 5 (-8 vs trimestre anterior) | 7 (+1 vs trimestre anterior) | -3.9M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Bleichroeder LP | $1.985.196 | 3.802.329 | 28,49% | Ações |
| Stonepine Capital Management, LLC | $1.729.292 | 3.312.185 | 24,82% | Ações |
| SPHERA FUNDS MANAGEMENT LTD. | $1.033.717 | 98.996 | 14,84% | Ações |
| Cable Car Capital, LP | $696.134 | 1.333.334 | 9,99% | Ações |
| CM Management, LLC | $287.155 | 550.000 | 4,12% | Ações |
| MORGAN STANLEY | $263.290 | 504.291 | 3,78% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $179.486 | 343.842 | 2,58% | Ações |
| M28 Capital Management LP | $148.741 | 284.889 | 2,13% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $142.044 | 272.044 | 2,04% | Ações |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $128.306 | 245.750 | 1,84% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $74.123 | 141.972 | 1,06% | Ações |
| VANGUARD GROUP INC | $60.862 | 61.664 | 0,87% | Ações |
| XTX Topco Ltd | $56.470 | 108.160 | 0,81% | Ações |
| NORTHERN TRUST CORP | $50.054 | 95.870 | 0,72% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $32.189 | 61.664 | 0,46% | Ações |
| BlackRock, Inc. | $27.846 | 53.334 | 0,40% | Ações |
| Focused Wealth Management, Inc | $26.131 | 50.049 | 0,38% | Ações |
| STATE STREET CORP | $10.990 | 21.049 | 0,16% | Ações |
| FRANKLIN STREET ADVISORS INC /NC | $10.442 | 20.000 | 0,15% | Ações |
| LPL Financial LLC | $7.819 | 14.977 | 0,11% | Ações |
| MAVERICK CAPITAL LTD | $6.194 | 49.554 | 0,09% | Ações |
| Dauntless Investment Group, LLC | $5.222 | 10.001 | 0,07% | Ações |
| BARCLAYS PLC | $3.641 | 6.973 | 0,05% | Ações |
| Steward Partners Investment Advisory, LLC | $1.356 | 2.597 | 0,02% | Ações |
| OSAIC HOLDINGS, INC. | $785 | 1.510 | 0,01% | Ações |
| GROUP ONE TRADING LLC | $235 | 450 | 0,00% | Ações |
| Axiom Investment Management LLC | $52 | 100 | 0,00% | Ações |
| JPMORGAN CHASE & CO | $48 | 108 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $39 | 120 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $29 | 55 | 0,00% | Ações |
| CWM, LLC | $28 | 51 | 0,00% | Ações |
| UBS Group AG | $16 | 31 | 0,00% | Ações |
| GSA CAPITAL PARTNERS LLP | $12 | 22.760 | 0,00% | Ações |
| CIBC Private Wealth Group LLC | $10 | 6 | 0,00% | Ações |
| WR Wealth Planners, LLC | $3 | 1 | 0,00% | Ações |
| Blue Trust, Inc. | $2 | 4 | 0,00% | Ações |
| VIMA LLC | $2 | 3 | 0,00% | Ações |
| MPWM ADVISORY SOLUTIONS, LLC | $1 | 2 | 0,00% | Ações |
| ROYAL BANK OF CANADA | $0 | 63 | 0,00% | Ações |
Executivos da empresa 33 insiders · 17 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| James E Dentzer | President & CEO | 7 de Julho de 2026 A | 148.730 | 0 | 0 | $0 |
| Ali Fattaey Ph.D. | President & CEO | 15 de Maio de 2018 A | 322.140 | 0 | 0 | $0 |
| Diantha Duvall | CFO | 7 de Julho de 2026 A | 77.707 | 0 | 0 | $0 |
| William Steinkrauss | Chief Financial Officer | 29 de Janeiro de 2022 A | — | 0 | 0 | $0 |
| Michael Gray | CFO | 27 de Maio de 2015 A | 107.304 | 0 | 0 | $0 |
| Mitchell Keegan | Vice-President | 7 de Janeiro de 2011 A | — | 0 | 0 | $0 |
| Jonathan B. Zung | CDO | 7 de Julho de 2026 A | 66.667 | 0 | 0 | $0 |
| Ahmed Hamdy MD | CMO | 20 de Março de 2026 C | 66.667 | 0 | 0 | $0 |
| Robert Martell | Head of Research & Development | 20 de Janeiro de 2023 A | 23.027 | 0 | 0 | $0 |
| David Tuck | Chief Medical Officer | 15 de Maio de 2018 A | 169.424 | 0 | 0 | $0 |
| Mani Mohindru | Chief Strategy Officer | 14 de Fevereiro de 2017 A | — | 0 | 0 | $0 |
| Jaye Viner | Chief Medical Officer | 27 de Maio de 2015 A | — | 0 | 0 | $0 |
| Mark Noel | VP, Tech Management | 2 de Maio de 2013 M | 27.540 | 0 | 0 | $0 |
| Changgeng Qian | VP, Research & Preclinical Dev | 7 de Janeiro de 2011 A | — | 0 | 0 | $0 |
| Mary Elizabeth Potthoff | VP and General Counsel | 31 de Maio de 2006 A | 0 | 0 | 0 | $0 |
| Lee L Rubin | VP of Research | 1 de Junho de 2005 A | 9.814 | 0 | 0 | $0 |
| Christopher U Missling | Sr. VP, Strategic Planning | 16 de Janeiro de 2004 M | 0 | 0 | 0 | $0 |
| Anne Elizabeth Borgman | Conselheiro | 7 de Julho de 2026 A | — | 0 | 0 | $0 |
| John Hohneker | Conselheiro | 7 de Julho de 2026 A | — | 0 | 0 | $0 |
| Marc Rubin | Conselheiro | 7 de Julho de 2026 A | 28.108 | 0 | 0 | $0 |
| Kenneth I Kaitin | Conselheiro | 7 de Julho de 2026 A | 11.407 | 1 | 0 | $5.500 |
| Martyn D Greenacre | Conselheiro | 7 de Julho de 2026 A | 26.089 | 0 | 0 | $0 |
| Lori Anne Kunkel | Conselheiro | 31 de Janeiro de 2022 A | 22.200 | 0 | 0 | $0 |
| James R Mcnab | Conselheiro | 5 de Maio de 2017 S | 50.000 | 0 | 0 | $0 |
| Kenneth Pienta | Conselheiro | 28 de Fevereiro de 2017 A | 30.000 | 0 | 0 | $0 |
| James R Tobin | Conselheiro | 26 de Janeiro de 2015 A | 144.921 | 0 | 0 | $0 |
| Susan B Bayh | Conselheiro | 17 de Janeiro de 2013 A | 25.000 | 0 | 0 | $0 |
| Joseph Davie MD PHD | Conselheiro | 7 de Janeiro de 2011 A | — | 0 | 0 | $0 |
| Stephen Carter | Conselheiro | 25 de Janeiro de 2008 A | — | 0 | 0 | $0 |
| Joseph M Davie | Conselheiro | 6 de Junho de 2007 A | 20.000 | 0 | 0 | $0 |
| Douglas Melton | Conselheiro | 23 de Agosto de 2006 A | 173.499 | 0 | 0 | $0 |
| Daniel R Passeri | — | 19 de Janeiro de 2016 A | 211.798 | 0 | 0 | $0 |
| Maurizio Voi | — | 17 de Janeiro de 2013 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Pessoa de relato não divulgada | 4 de Março de 2004 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 29 de Janeiro de 2004 | — | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada | 4 de Junho de 2003 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.